coenzyme a has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonescu, C; Astori, A; Fairn, GD; Khosraviani, N; Latreille, E; Lee, M; Lee, WL; Li, Z; Mekhail, K; Raught, B; Rini, J; St-Germain, J; Sugiyama, M; Wei, K | 1 |
1 other study(ies) available for coenzyme a and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
FASN inhibitor TVB-3166 prevents S-acylation of the spike protein of human coronaviruses.
Topics: Acylation; Acyltransferases; Alkynes; Azetidines; Coenzyme A; COVID-19; Cysteine; Fatty Acid Synthase, Type I; Humans; Myristates; Nitriles; Palmitates; Pyrazoles; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Stearates | 2022 |